|
Type. Speak. Connect. We’ve designed a new way to support you. |
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
MEET CLAIRE… Your keyboard and voice-activated Virtual Health Assistant.
BE EMPOWERED. Ask Claire about the freedom of 3-times-a-week dosing. COPAXONE® (glatiramer acetate injection)—the brand you know and trust—is available in a 3-times-a-week dose. Experience the freedom to choose a dosing schedule that works for you—including injection-free weekends!* The 3-times-a-week dose adds to the existing benefits of COPAXONE®:
†Based on total number of prescriptions for relapsing forms of MS (IMS National Rx Audit, May 2014). |
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
COPAXONE® is indicated for the treatment of patients with relapsing forms of multiple sclerosis. Important Safety Information Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol. Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again. Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense. A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes. The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information. 
References: 1. COPAXONE® (glatiramer acetate injection) prescribing information. Rev. 1/2014. Teva Neuroscience, Inc. 2. IMS Health National Prescription Audit, May 2014. Data proprietary to IMS Health. Privacy Notice | One Click Unsubscribe | Terms of Use |
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
